Prompt clinical and biochemical response to denosumab in a young adult patient with craniofacial fibrous dysplasia.

CONCLUSION: Denosumab appears to be effective in reducing bone turnover and bone pain in adult patients with active MFD.
PMID: 28228794 [PubMed - in process]

Source: Clinical Cases in Mineral and Bone Metabolism - February 24, 2017 Category: Orthopaedics Tags: Clin Cases Miner Bone Metab Source Type: research